Skip to main content
Premium Trial:

Request an Annual Quote

DoD Awards BioFire Dx $27.4M Contract

NEW YORK (GenomeWeb News) – The US Department of Defense has awarded BioFire Diagnostics, formerly called Idaho Technology, a contract for up to $27.4 million.

In an announcement last week, the Defense Logistics Agency of DOD said the award is a modification on the second option year of a previously awarded contract and is a firm fixed-price, sole-source, indefinite delivery and indefinite quantity contract for reagents, extraction, and inhibition kits.

The military services that may use the kit are the Army, Navy, Air Force, Marine Corps, and federal civilian agencies, DLA said. The date of performance completion is Aug. 31, 2013.

Salt Lake City-based BioFire declined to provide further details about the contract.

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.